Clinical Sandoz biosimilar trial hailed as 'landmark' Patients switched between the originator and the near-copy.
UK & Europe Amgen's Kyprolis gains expanded myeloma use in Europe Kyprolis gains label expansion in Europe
News Pfizer cholesterol drug succeeds in two late stage trials Pfizer's bococizumab cholesterol drug has met primary endpoint in two phase 3 trials, part of a series of six late-stage studies.
News US regulatory advisers to review Amgen's Humira biosimilar World's biggest selling drug could face competition.
Articles US physicians favour biosimilars As the US FDA moves towards issuing final guidelines on biosimilars, recent research with specialists in five main therapy areas suggests they are willing to embrace them if efficacy and safety
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.